Satellos Bioscience Inc. ("Satellos" or the "Company"), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, announced today its financial ...

“The week 16 data of lebrikizumab […] points towards a drug with robust efficacy with hardly any safety trade-offs ... to fit patients’ needs. “[L]ess frequent doses might be translated ...

As Europe accelerates its shift to renewable energy, the need for grid stability and flexibility has never been greater.

This approach comprehensively verified the safety protection capabilities of the Smart String & Grid Forming ESS in extreme ignition scenarios, setting a new benchmark for safety testing.

This groundbreaking test, conducted under real-world scenarios and innovative methodologies, validates the ESS's capabilities in extreme conditions, marking a significant milestone in advancing safety ...